T Cell Types and Functions
Regulation of Angiogenesis and Blood Supply
Inflammatory Response
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Tumor Microenvironment
Receptor Downregulation in MVBs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 3, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
Kensuke Tanaka1, Kento Yoshioka2, Koichiro Tatsumi3
1Department of Biochemistry and Molecular Pharmacology, Graduate School of Medicine, Chiba University, Chiba 2608670, Japan; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Endothelin (ET) receptor blocker BQ123 significantly inhibits interleukin-17 (IL-17) production by Th17 cells, suggesting potential for multiple sclerosis treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: